Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus.
Virus-host interactions involve complex interplay between viral and host factors, rendering them an ideal target for proteomic analysis. Here we detail a high throughput quantitative proteomics analysis of Vero cells infected with the coronavirus infectious bronchitis virus (IBV), a positive strand RNA virus that replicates in the cytoplasm. Stable isotope labeling with amino acids in cell culture (SILAC) was used in conjunction with LC-MS/MS to identify and quantify 1830 cellular and two viral proteins from IBV-infected cells. Fractionation of cells into cytoplasmic, nuclear, and nucleolar extracts was used to reduce sample complexity and provide information on the trafficking of proteins between the different compartments. Each fraction showed a proportion of proteins exhibiting >or=2-fold changes in abundance. Ingenuity Pathway Analysis revealed that proteins that changed in response to infection could be grouped into different functional categories. These included proteins regulated by NF-kappaB- and AP-1-dependent pathways and proteins involved in the cytoskeleton and molecular motors. A luciferase-based reporter gene assay was used to validate the up-regulation of AP-1- and NF-kappaB-dependent transcription in IBV-infected cells and confirmed using immunofluorescence. Immunofluorescence was used to validate changes in the subcellular localization of vimentin and myosin VI in IBV-infected cells. The proteomics analysis also confirmed the presence of the viral nucleocapsid protein as localizing in the cytoplasm, nucleus, and nucleolus and the viral membrane protein in the cytoplasmic fraction. This research is the first application of SILAC to study total host cell proteome changes in response to positive sense RNA virus infection and illustrates the versatility of this technique as applied to infectious disease research.
Emmott
Edward
E
Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
Rodgers
Mark A
MA
Macdonald
Andrew
A
McCrory
Sarah
S
Ajuh
Paul
P
Hiscox
Julian A
JA
D000595:Amino Acid Sequence; D000818:Animals; D002466:Cell Nucleolus / Q000737:chemistry*; D002467:Cell Nucleus / Q000737:chemistry*; D002522:Chlorocebus aethiops; D002853:Chromatography, Liquid; D003593:Cytoplasm / Q000737:chemistry*; D004591:Electrophoresis, Polyacrylamide Gel; D001351:Infectious bronchitis virus / Q000472:pathogenicity*; D007553:Isotope Labeling / Q000379:methods*; D018613:Microscopy, Confocal; D008969:Molecular Sequence Data; D040901:Proteomics; D053719:Tandem Mass Spectrometry / Q000379:methods; D014709:Vero Cells; D014764:Viral Proteins / Q000737:chemistry*
D014764:Viral Proteins
J Virol. 2004 Nov;78(21):11461-76
15479789
Biochem Biophys Res Commun. 2003 Nov 28;311(4):870-6
14623261
J Virol. 2007 Jan;81(1):20-9
16928755
FEBS Lett. 2006 Oct 30;580(25):5993-8
17052713
Virology. 2008 Oct 25;380(2):191-202
18775548
J Proteome Res. 2007 Dec;6(12):4592-600
17979228
J Virol. 1998 Jun;72(6):4918-24
9573259
Mol Cell Proteomics. 2006 Dec;5(12):2319-25
16943187
PLoS One. 2009;4(3):e4908
19287488
Arch Virol. 2008;153(9):1777-81
18695932
Mol Cell Proteomics. 2010 Jan;9(1):117-30
19812395
Virology. 2007 Sep 1;365(2):435-45
17493653
Curr Biol. 2002 Jan 8;12(1):1-11
11790298
Mol Cell Proteomics. 2005 Jul;4(7):902-13
15784933
J Virol. 2009 May;83(10):5282-8
19264783
J Gen Virol. 2009 Sep;90(Pt 9):2147-56
19458173
Autophagy. 2008 Apr;4(3):276-9
18032917
J Virol. 2008 Oct;82(19):9689-99
18653448
Virology. 1996 Jul 15;221(2):325-34
8661443
J Cell Sci. 2006 Jun 15;119(Pt 12):2621-31
16763197
J Virol. 2002 May;76(10):5233-50
11967337
J Virol. 2008 Sep;82(17):8664-72
18562526
Cell Cycle. 2007 Apr 1;6(7):863-7
17426449
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15190-5
17005724
Virology. 2007 Jul 5;363(2):397-409
17346762
J Virol. 2004 Oct;78(19):10410-9
15367607
J Virol. 2004 Feb;78(4):1865-72
14747551
J Virol. 2001 Jan;75(1):506-12
11119619
J Virol. 2009 Jul;83(13):6631-40
19403678
Mol Cell Biol. 2003 Aug;23(16):5790-802
12897149
J Cell Sci. 2005 Dec 15;118(Pt 24):5785-96
16339966
Cell Microbiol. 2006 Jul;8(7):1147-57
16819967
Mol Cell. 2006 Sep 1;23(5):749-55
16949370
Nat Rev Mol Cell Biol. 2006 Dec;7(12):952-8
17139335
Annu Rev Microbiol. 2006;60:211-30
16712436
EMBO Rep. 2009 Mar;10(3):231-8
19229283
J Virol. 2005 Jan;79(2):1164-79
15613344
Nat Biotechnol. 2008 Dec;26(12):1367-72
19029910
FEBS Lett. 2007 Apr 3;581(7):1275-86
17359980
Virology. 2008 Jan 20;370(2):373-81
17931676
Nat Rev Microbiol. 2007 Feb;5(2):119-27
17224921
Vaccine. 2009 Nov 5;27(47):6642-8
19773098
Arch Virol. 2002 Jun;147(6):1077-89
12111420
Avian Pathol. 2005 Dec;34(6):439-48
16537157
J Biol Chem. 2007 Mar 2;282(9):6232-41
17202147
J Virol. 2004 Jun;78(11):5658-69
15140963
Mol Cell Proteomics. 2005 Dec;4(12):2010-21
16249172
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000
14569023
J Virol. 2007 Jan;81(2):548-57
17108024
Virology. 2009 Feb 5;384(1):209-15
19059617
Virology. 2003 Jul 20;312(1):25-34
12890618
Virol J. 2007 Jan 15;4:7
17224050
Arch Virol. 1992;122(3-4):307-16
1309994
Trends Microbiol. 1996 Jul;4(7):264-9
8829334
Nat Cell Biol. 2002 May;4(5):E131-6
11988758
Mol Cell Proteomics. 2008 Mar;7(3):612-25
18056921
Oncogene. 2001 Apr 30;20(19):2390-400
11402335
J Virol. 2005 Sep;79(18):11766-75
16140754
Anal Chem. 1996 Mar 1;68(5):850-8
8779443
Virus Res. 2007 Sep;128(1-2):1-8
17532082
J Virol. 2007 Apr;81(8):4298-304
17202223
J Virol. 2009 Jul;83(13):6689-705
19369340
J Virol. 2008 May;82(10):4762-73
18321972
J Biol Chem. 2004 Mar 12;279(11):10136-41
14699140
J Virol. 2001 Jan;75(2):1031-8
11134316
J Virol. 2002 Feb;76(4):1839-55
11799179
FEBS Lett. 2004 Sep 10;574(1-3):116-20
15358550
Rev Med Virol. 2009 Jul;19(4):201-14
19399920
J Immunol. 2000 Oct 1;165(7):3951-8
11034403
Virology. 2001 Jun 20;285(1):21-9
11414802
PLoS Genet. 2008 Oct 03;4(10):e1000207
18833301
PLoS Pathog. 2008 Jul 11;4(7):e1000100
18617993
J Virol. 2000 May;74(9):4319-26
10756047
Virology. 1998 Oct 10;250(1):41-9
9770418
J Med Virol. 2007 Oct;79(10):1431-9
17705188
PLoS Pathog. 2008 May 02;4(5):e1000054
18451981
Mol Cell Biol. 2006 Mar;26(6):2175-86
16507995
J Virol. 2001 Oct;75(19):9345-56
11533198
J Virol. 2006 Apr;80(8):4147-56
16571830
Traffic. 2006 Jul;7(7):833-48
16734668
Nat Med. 2004 Dec;10(12 Suppl):S88-97
15577937
J Immunol. 2004 Dec 15;173(12):7602-14
15585888
Mol Biol Cell. 2003 Jul;14(7):2728-43
12857860
J Gen Virol. 2006 Jul;87(Pt 7):1961-1975
16760398
Virology. 2007 Jan 20;357(2):215-27
16979208